decreased fasted circulating glucose level_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>

http://metadb.riken.jp/0013278I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd

decreased fasted circulating glucose level_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• solute carrier family 43, member 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:2442746

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Slc43a2<Gt(258C1)Cmhd>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased fasted circulating glucose level
  http://purl.obolibrary.org/obo/MP_0013278

文献

http://purl.org/net/cito/citesAsAuthority

• Adriano. Guetg, et.al., Essential amino acid transporter Lat4 (Slc43a2) is required for mouse development., The Journal of physiology, 2015, 593
  http://rdf.ncbi.nlm.nih.gov/pubmed/25480797